Assoc. Prof. Ruth Ladenstein, MD, was invited to the EU-Parliament to present key considerations for revision of the EU Clinical Trials Directive
Hosted by Member of the European Parliament (MEP) Mrs. Glenis Willmott (UK), the event involved Assoc. Prof. Ruth Ladenstein, MD, and a range of stakeholders involved in paediatric oncology and health policy issues to debate the many challenges childhood cancer presents and to jointly find a political pathway to instigate change. The revision of the EU Clinical Trials Directive, the EU Paediatric
Regulation and earlier diagnosis campaigns were discussed.